142 related articles for article (PubMed ID: 12774849)
1. Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells.
Vásquez C; Navarro-Polanco RA; Huerta M; Trujillo X; Andrade F; Trujillo-Hernández B; Hernández L
Can J Physiol Pharmacol; 2003 May; 81(5):436-42. PubMed ID: 12774849
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
Guo J; Ikeda SR
Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
[TBL] [Abstract][Full Text] [Related]
4. Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta.
Van den Bossche I; Vanheel B
Br J Pharmacol; 2000 Sep; 131(1):85-93. PubMed ID: 10960073
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels.
Romano MR; Lograno MD
Br J Pharmacol; 2006 Apr; 147(8):917-25. PubMed ID: 16474412
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.
Twitchell W; Brown S; Mackie K
J Neurophysiol; 1997 Jul; 78(1):43-50. PubMed ID: 9242259
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
[TBL] [Abstract][Full Text] [Related]
8. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids decrease the K(+) M-current in hippocampal CA1 neurons.
Schweitzer P
J Neurosci; 2000 Jan; 20(1):51-8. PubMed ID: 10627580
[TBL] [Abstract][Full Text] [Related]
10. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
11. Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2.
Fan SF; Yazulla S
Vis Neurosci; 2003; 20(2):177-88. PubMed ID: 12916739
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current.
Gebremedhin D; Lange AR; Campbell WB; Hillard CJ; Harder DR
Am J Physiol; 1999 Jun; 276(6):H2085-93. PubMed ID: 10362691
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons.
Fisyunov A; Tsintsadze V; Min R; Burnashev N; Lozovaya N
J Neurophysiol; 2006 Sep; 96(3):1267-77. PubMed ID: 16738209
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.
McAllister SD; Griffin G; Satin LS; Abood ME
J Pharmacol Exp Ther; 1999 Nov; 291(2):618-26. PubMed ID: 10525080
[TBL] [Abstract][Full Text] [Related]
15. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
Mackie K; Devane WA; Hille B
Mol Pharmacol; 1993 Sep; 44(3):498-503. PubMed ID: 8371711
[TBL] [Abstract][Full Text] [Related]
16. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).
Smart D; Gunthorpe MJ; Jerman JC; Nasir S; Gray J; Muir AI; Chambers JK; Randall AD; Davis JB
Br J Pharmacol; 2000 Jan; 129(2):227-30. PubMed ID: 10694225
[TBL] [Abstract][Full Text] [Related]
17. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
18. Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.
Pan X; Ikeda SR; Lewis DL
Mol Pharmacol; 1996 Apr; 49(4):707-14. PubMed ID: 8609900
[TBL] [Abstract][Full Text] [Related]
19. The agonists for nociceptors are ubiquitous, but the modulators are specific: P2X receptors in the sensory neurons are modulated by cannabinoids.
Krishtal O; Lozovaya N; Fedorenko A; Savelyev I; Chizhmakov I
Pflugers Arch; 2006 Dec; 453(3):353-60. PubMed ID: 16741755
[TBL] [Abstract][Full Text] [Related]
20. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
Ameri A; Wilhelm A; Simmet T
Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
